NeurATRIS NeurATRIS
  • English version
  • Version Française

  • Home

    Home

  • NeurATRIS

    NeurATRIS

    • Who are we ?

      Who are we ?

    • Objectives: Research and Services

      Objectives: Research and Services

    • Management

      Management

    • NeurATRIS Network

      NeurATRIS Network

      • Institutional network

        Institutional network

      • Scientific and medical network

        Scientific and medical network

  • Research Programs

    Research Programs

    • Cellular therapies

      Cellular therapies

    • Gene therapies

      Gene therapies

    • In vivo evaluation and therapeutic efficacy

      In vivo evaluation and therapeutic efficacy

    • Drug therapies

      Drug therapies

  • The NeurATRIS Offer

    The NeurATRIS Offer

    • NeurARIS' actions

      NeurARIS' actions

      • Training support

        Training support

      • Research support

        Research support

      • Scientific events

        Scientific events

    • Our tools

      Our tools

      • ALZHEIMER

        ALZHEIMER

      • PARKINSON

        PARKINSON

      • HUNTINGTON

        HUNTINGTON

      • MULTIPLE SCLEROSIS

        MULTIPLE SCLEROSIS

      • NEURODEVELOPMENTAL DISORDERS

        NEURODEVELOPMENTAL DISORDERS

    • NeurAtris platforms

      NeurAtris platforms

      • NeurAtris platforms

        NeurAtris platforms

      • CEA Paris- Saclay / MIRCen platforms

        CEA Paris- Saclay / MIRCen platforms

      • ICM platforms - GHU Pitié Salpêtrière

        ICM platforms - GHU Pitié Salpêtrière

      • Henri Mondor Hospital platforms

        Henri Mondor Hospital platforms

      • N-BIPS Bicêtre Hospital Platforms

        N-BIPS Bicêtre Hospital Platforms

      • Oniris Nantes / INRAE platforms

        Oniris Nantes / INRAE platforms

      • Robert-Debré Hospital/NeuroDiderot platforms

        Robert-Debré Hospital/NeuroDiderot platforms

      • I-Stem Platforms

        I-Stem Platforms

    • A continuum in translational research

      A continuum in translational research

    • How to collaborate

      How to collaborate

    • Submit a project

      Submit a project

  • EATRIS

    EATRIS

  • Search

    Search

  • Home
  • NeurATRIS
    • Who are we ?
    • Objectives: Research and Services
    • Management
    • NeurATRIS Network
      • Institutional network
      • Scientific and medical network
  • Research Programs
    • Cellular therapies
    • Gene therapies
    • In vivo evaluation and therapeutic efficacy
    • Drug therapies
  • The NeurATRIS Offer
    • NeurARIS' actions
      • Training support
      • Research support
      • Scientific events
    • Our tools
      • ALZHEIMER
      • PARKINSON
      • HUNTINGTON
      • MULTIPLE SCLEROSIS
      • NEURODEVELOPMENTAL DISORDERS
    • NeurAtris platforms
      • NeurAtris platforms
      • CEA Paris- Saclay / MIRCen platforms
      • ICM platforms - GHU Pitié Salpêtrière
      • Henri Mondor Hospital platforms
      • N-BIPS Bicêtre Hospital Platforms
      • Oniris Nantes / INRAE platforms
      • Robert-Debré Hospital/NeuroDiderot platforms
      • I-Stem Platforms
    • A continuum in translational research
    • How to collaborate
    • Submit a project
  • EATRIS
  • Search
  • News
  • Schedule
  • Contact

News

  • Opening of the France Parkinson 2025 Calls for Projects

    Read More ...

  • NeurATRIS wishes you a happy new year 2025!

    Read More ...

  • Exceptional Lecture by Prof. Klämbt at the ICM on January 9, 2025

    Read More ...

  • NeurATRIS secures €4.8M in funding to renew its equipment and accelerate its technological developments.

    Read More ...

  • Travel grants for the 5th edition of the GRC on Parkinson's disease

    Read More ...

  • SAVE THE DATE : NeurATRIS Annual General Meeting

    Read More ...

Read all news

Schedule

2025 Parkinson's Disease Conference GRC
From 8. Jun 2025 Until 13. Jun 2025

2025 Parkinson's Disease Conference GRC

See all schedule

Contacts
Legals

This website is using Cookies. By navigating, you accept this use.